title: The biology of thrombopoietin and thrombopoietin receptor agonists.
abstract: Thrombopoietin (TPO) is the major physiological regulator of platelet production. TPO binds the TPO receptor, activates JAK and STAT pathways, thus stimulating megakaryocyte growth and platelet production. There is no "sensor" of the platelet count; rather TPO is produced in the liver at a constant rate and cleared by TPO receptors on platelets. TPO levels are inversely proportional to the rate of platelet production. Early recombinant TPO molecules were potent stimulators of platelet production and increased platelets in patients with immune thrombocytopenia, chemotherapy-induced thrombocytopenia, myelodysplastic syndromes and platelet apheresis donors. Neutralizing antibodies formed against one recombinant protein and ended their development. A second generation of TPO receptor agonists, romiplostim and eltrombopag, has been developed. Romiplostim is an IgG heavy chain into which four TPO agonist peptides have been inserted. Eltrombopag is an oral small molecule. These activate the TPO receptor by different mechanisms to increase megakaryocyte growth and platelet production. After administration of either to healthy volunteers, there is a delay of 5 days before the platelet count rises and subsequently reaches a peak after 12-14 days. Both have been highly effective in treating ITP and hepatitis C thrombocytopenia. Studies in a wide variety of other thrombocytopenic conditions are underway.
authors.affiliation: Harvard Medical School, Boston, MA, USA. kuter.david@mgh.harvard.edu
authors.forename: David J
authors.initials: DJ
authors.lastname: Kuter
mesh_terms: D000818:Animals; D006401:Hematologic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D053628:Receptors, Thrombopoietin / Q000819:agonists* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D013921:Thrombocytopenia / Q000188:drug therapy / Q000378:metabolism; D034061:Thrombopoiesis / Q000187:drug effects*; D013926:Thrombopoietin / Q000819:agonists* / Q000378:metabolism
chemical_list: D006401:Hematologic Agents; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; D013926:Thrombopoietin